Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression

被引：0
作者：
Gieira S. Jones
Katherine A. Hoadley
Halei Benefield
Linnea T. Olsson
Alina M. Hamilton
Arjun Bhattacharya
Erin L. Kirk
Heather J. Tipaldos
Jodie M. Fleming
Kevin P. Williams
Michael I. Love
Hazel B. Nichols
Andrew F. Olshan
Melissa A. Troester
机构：
[1] University of North Carolina-Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[2] University of North Carolina-Chapel Hill-Chapel Hill,Department of Genetics
[3] University of North Carolina,Lineberger Comprehensive Cancer Center
[4] University of North Carolina-Chapel Hill,Department of Pathology and Laboratory Medicine
[5] University of North Carolina-Chapel Hill,Department of Biostatistics
[6] University of California,Department of Pathology and Laboratory Medicine, David Geffen School of Medicine
[7] University of California,Institute for Quantitative and Computational Biosciences, David Geffen School of Medicine
[8] North Carolina Central University,Department of Biological and Biomedical Sciences
[9] North Carolina Central University,Biomanufacturing Research Institute and Technology Enterprise
[10] North Carolina Central University,Department of Pharmaceutical Sciences
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
Breast cancer; Hepatocyte growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 455
页数：8
相关论文
共 227 条
[1]  
Benefield HC(2019)Borderline estrogen receptor-positive breast cancers in Black and White women JNCI 112 728-736
[2]  
Allott EH(2019)Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia NPJ Breast Cancer 26 1-7
[3]  
Reeder-Hayes KE(2018)Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer Clin Exp Metastasis 35 613-623
[4]  
Perou CM(2017)Risk of recurrence and mortality in a multi-ethnic breast cancer population J Racial Ethn Health Disparities 4 1181-1188
[5]  
Carey LA(2006)Meta-analysis of survival in African American and White American patients with breast cancer: ethnicity compared with socioeconomic status J Clin Oncol 24 1342-1349
[6]  
Geradts J(2017)Racial differences in PAM50 subtypes in the Carolina Breast Cancer Study J Natl Cancer Inst 110 176-182
[7]  
Collin LJ(2011)Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists Modern Pathol 24 157-167
[8]  
Yan M(2017)Targeting epidermal growth factor receptor in triple negative breast cancer: new discoveries and practical insights for drug development Cancer Treat Rev 53 111-119
[9]  
Jiang R(2019)Molecular targeting therapy against EGFR family in breast cancer: progress and future potentials Cancers 11 1826-2334
[10]  
Ward KC(2007)The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes Clin Cancer Res 13 2329-682
12345678910